Investors
Information Disclosure
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 20242024.05.06
-
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR MARKETING OF CATEGORY 1 INNVOATIVE DRUG UNECRITNIB FUMARATE CAPSULES "UNECRITINIB (TQ-B3101)"2024.04.30
-
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)2024.04.29
-
NOTICE OF ANNUAL GENERAL MEETING2024.04.29
-
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES; RE-ELECTION OF DIRECTORS; AND NOTICE OF ANNUAL GENERAL MEETING2024.04.29
-
2023 ANNUAL REPORT2024.04.29
-
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS2024.04.29
-
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS2024.04.29